At today's Capital Markets Day BONESUPPORT AB will provide further insight into the company's operations and strategy. The focus is the US launch of BONESUPPORT's antibiotic eluting product CERAMENT G.
BONESUPPORT's group management will, among other things, announce the following:
- CERAMENT G has been included in the contracts with Healthtrust (approx. 1,500 hospitals) and Premier (approx. 2,500 hospitals) as of October 1, 2022.
- Launch of the "Booster program" – a focused effort to efficiently penetrate the American market with CERAMENT G.
- Updated financial goal: 40% sales growth in the next three years (2023–2025)
The Capital Markets Day takes place today, Thursday 1 September, 14:00-16:30 at Helio, Grev Turegatan 30, in Stockholm. For physical attendance, please register here: https://financialhearings.com/event/44406
The Capital Markets Day will also be broadcast live at https://tv.streamfabriken.com/bonesupport-cmd-2022.